文献速递炎症性肠病消化内镜

内镜下狭窄切开术与回结肠切除术治疗克罗恩病回结肠吻合口狭窄的比较

Endoscopic stricturotomy versus ileocolonic resection in the treatment of ileocolonic anastomotic strictures in Crohn's disease.
PubMed 文献 · Gastrointest Endosc · 2019-01-30

这项历史性队列研究纳入2010至2017年连续接受内镜下狭窄切开术(ESt,35例)或回结肠切除术(ICR,147例)的克罗恩病回结肠吻合口狭窄患者,比较无手术生存与术后不良事件。ESt组与ICR组后续狭窄相关手术率无显著差异,但ESt组操作相关重大不良事件发生率更低。

要点

  • ESt组与ICR组后续狭窄相关手术率分别为11.3%与10.2%,无显著差异(P=.83)。
  • ESt组操作相关重大不良事件发生率为每例操作10.2%(5/49),低于ICR组的31.9%(P=.003)。
  • 术前使用糖皮质激素、多发狭窄和疾病相关住院次数增加与无手术生存期缩短相关。

核心结论

  • 在随访时间较短的局限性下,ESt与ICR相比获得相当的无手术生存率,且发病率降低。

研究设计与样本

  • 历史性队列研究,纳入2010至2017年连续接受ESt或ICR治疗的克罗恩病回结肠吻合口狭窄患者,ESt组35例,ICR组147例。

主要发现

  • ESt组中位随访0.8年(四分位距[IQR]0.2-1.7),ICR组中位随访2.2年(IQR 1.2-4.4),P<.001。
  • ESt组4例(11.3%)需后续狭窄相关手术,ICR组15例(10.2%)需后续狭窄相关手术,P=.83。
  • Kaplan-Meier分析显示两组无手术生存率无统计学差异(P=.24)。
  • ESt组49例次操作中5例次(每例操作10.2%)记录到操作相关重大不良事件,ICR组47例(31.9%)发生操作相关重大不良事件,P=.003。
  • 多因素分析中无手术生存期缩短的危险因素包括术前使用糖皮质激素(风险比[HR]2.8;95%置信区间[CI]1.0-8.1)、多发狭窄(HR 4.9;95%CI 1.7-14.2)和疾病相关住院次数增加(HR 4.0;95%CI 1.2-13.0)。

局限性

  • 随访时间较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic stricturotomy (ESt) is a novel technique in the treatment of anastomotic strictures in Crohn's disease (CD). The aim of this study was to compare the outcome of patients with ileocolonic anastomotic stricture treated with ESt versus ileocolonic resection (ICR). METHODS: This historical cohort study included consecutive CD patients with ileocolonic anastomotic stricture treated with ESt or ICR from 2010 to 2017. The primary outcomes were surgery-free survival and postprocedural adverse events. RESULTS: Thirty-five patients treated with ESt and 147 patients treated with ICR were analyzed. Median follow-up was .8 years (interquartile range [IQR], .2-1.7) and 2.2 years (IQR, 1.2-4.4) in the ESt and ICR groups, respectively (P < .001). Subsequent stricture-related surgery was needed in 4 patients (11.3%) receiving ESt and in 15 patients (10.2%) receiving ICR (P = .83). Kaplan-Meier analysis also showed no statistical difference regarding surgery-free survival between the 2 groups (P = .24). Procedure-related major adverse events were documented in 5 of 49 patients (10.2% per procedure) undergoing ESt and 47 patients (31.9%) undergoing ICR (P = .003). Risk factors for decreased surgery-free survival on multivariate analysis included preprocedural corticosteroids (hazard ratio [HR], 2.8; 95% confidence interval [CI], 1.0-8.1), multiple strictures (HR, 4.9; 95% CI, 1.7-14.2), and increased disease-related hospitalizations (HR, 4.0; 95% CI, 1.2-13.0). CONCLUSIONS: With the limitation of a shorter follow-up, ESt achieved comparable surgery-free survival with a decreased morbidity when compared with ICR.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Lan N, Stocchi L, Delaney CP, et al. Endoscopic stricturotomy versus ileocolonic resection in the treatment of ileocolonic anastomotic strictures in Crohn's disease. Gastrointest Endosc. 2019. PMID: 30710508. doi:10.1016/j.gie.2019.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。